Archive: 02/01/2019
Lipo-protein apheresis and PCSK9-inhibitors
Research suggests a specific treatment for Homozygous Familial Hypercholesterolaemic (HoFH) pateints; a combination therapy with PCSK9-inhibitors (PCSK9-I) and lipoprotein-apheresis (LA) may have synergistic effects on circulating ...
Jan 2, 2019
Exploration of umbelliferone based derivatives as potent MAO inhibitors
Monoamine oxidase (MAO) inhibitors are potential drug candidates for treating neurological disorders such as anxiety, Alzheimer's disease and Parkinson's disease.
Jan 2, 2019
Familial hypercholesterolemia in children and adolescents: diagnosis and treatment
Familial hypercholesterolemia is a hereditary genetic disorder predisposing in premature atherosclerosis and cardiovascular complications. Early diagnoses as well as effective treatment strategies in affected children are ...
Jan 2, 2019
Is very low LDL-C harmful?
A major Cardiovascular (CV) risk factor is low-density Lipoprotein Cholesterol (LDL-C). A lot of evidence that was accumulated supports a linear association between LDL-C levels and CV risk. However, whether the lower limit ...
Jan 2, 2019
Congolese flee to Uganda after vote, raising Ebola fears
A Red Cross official says hundreds of refugees have crossed into Uganda from Congo in the aftermath of that country's presidential election, heightening concerns about the possible cross-border spread of Ebola.
Jan 2, 2019
From a molecule of natural origin, new therapeutic opportunities against hypertension
Spirulina is celebrated as a so-called "superfood" because of its possible beneficial properties, though its mechanism of action is still under investigation. With the scientific name of Arthrospira platensis, spirulina is ...
Jan 2, 2019